
Anne Marie Falk
Examiner (ID: 427)
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 685 |
| Issued Applications | 242 |
| Pending Applications | 153 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9676675
[patent_doc_number] => 08815585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => 'Automated method and apparatus for embryonic stem cell culture'
[patent_app_type] => utility
[patent_app_number] => 12/164969
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 14160
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12164969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/164969 | Automated method and apparatus for embryonic stem cell culture | Jun 29, 2008 | Issued |
Array
(
[id] => 5546653
[patent_doc_number] => 20090156530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Norepinepherine Transporter Mutants and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/146188
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29223
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12146188
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/146188 | Norepinepherine Transporter Mutants and Uses Thereof | Jun 24, 2008 | Abandoned |
Array
(
[id] => 8527667
[patent_doc_number] => 08304237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Method and device for forming biologic cell aggregates'
[patent_app_type] => utility
[patent_app_number] => 12/665325
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 3972
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665325
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665325 | Method and device for forming biologic cell aggregates | Jun 12, 2008 | Issued |
Array
(
[id] => 5264435
[patent_doc_number] => 20090117120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Transgenic animal model for alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 12/157664
[patent_app_country] => US
[patent_app_date] => 2008-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15292
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117120.pdf
[firstpage_image] =>[orig_patent_app_number] => 12157664
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/157664 | Transgenic animal model for alzheimer's disease | Jun 10, 2008 | Issued |
Array
(
[id] => 6367876
[patent_doc_number] => 20100251392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'METHODS FOR ASSESSING THE DELIVERY OF EXOGENOUS AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/114609
[patent_app_country] => US
[patent_app_date] => 2008-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8057
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20100251392.pdf
[firstpage_image] =>[orig_patent_app_number] => 12114609
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/114609 | METHODS FOR ASSESSING THE DELIVERY OF EXOGENOUS AGENTS | May 1, 2008 | Abandoned |
Array
(
[id] => 8257216
[patent_doc_number] => 08206699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells'
[patent_app_type] => utility
[patent_app_number] => 12/111839
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 34
[patent_no_of_words] => 10351
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12111839
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/111839 | Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells | Apr 28, 2008 | Issued |
Array
(
[id] => 4759904
[patent_doc_number] => 20080312130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'DRUG DELIVERY VEHICLE FOR CANCER THERAPY, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATION USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/054200
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10085
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12054200
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/054200 | DRUG DELIVERY VEHICLE FOR CANCER THERAPY, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATION USING THE SAME | Mar 23, 2008 | Abandoned |
Array
(
[id] => 4927010
[patent_doc_number] => 20080166373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 12/053479
[patent_app_country] => US
[patent_app_date] => 2008-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11651
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20080166373.pdf
[firstpage_image] =>[orig_patent_app_number] => 12053479
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/053479 | METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS | Mar 20, 2008 | Abandoned |
Array
(
[id] => 4710564
[patent_doc_number] => 20080299090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Use Of Umbilical Cord Matrix Cells'
[patent_app_type] => utility
[patent_app_number] => 12/053167
[patent_app_country] => US
[patent_app_date] => 2008-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24159
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299090.pdf
[firstpage_image] =>[orig_patent_app_number] => 12053167
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/053167 | Use Of Umbilical Cord Matrix Cells | Mar 20, 2008 | Abandoned |
Array
(
[id] => 4431733
[patent_doc_number] => 07968337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Neural precursor cells, method for the production and use thereof in neural defect therapy'
[patent_app_type] => utility
[patent_app_number] => 12/048840
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 32
[patent_no_of_words] => 13784
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968337.pdf
[firstpage_image] =>[orig_patent_app_number] => 12048840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/048840 | Neural precursor cells, method for the production and use thereof in neural defect therapy | Mar 13, 2008 | Issued |
Array
(
[id] => 6520095
[patent_doc_number] => 20100203111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'G-SUBSTRATE FOR THE TREATMENT AND PREVENTION OF PARKINSON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/531044
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11408
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203111.pdf
[firstpage_image] =>[orig_patent_app_number] => 12531044
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531044 | G-substrate for the treatment and prevention of parkinson's disease | Mar 10, 2008 | Issued |
Array
(
[id] => 5386415
[patent_doc_number] => 20090227660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'GLP-1 gene delivery for the treatment of type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/074865
[patent_app_country] => US
[patent_app_date] => 2008-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6805
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227660.pdf
[firstpage_image] =>[orig_patent_app_number] => 12074865
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/074865 | GLP-1 gene delivery for the treatment of type 2 diabetes | Mar 4, 2008 | Abandoned |
Array
(
[id] => 8352056
[patent_doc_number] => 08247385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Treatment and prevention of neurodegenerative diseases using gene therapy'
[patent_app_type] => utility
[patent_app_number] => 12/025684
[patent_app_country] => US
[patent_app_date] => 2008-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 15340
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12025684
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/025684 | Treatment and prevention of neurodegenerative diseases using gene therapy | Feb 3, 2008 | Issued |
Array
(
[id] => 4926959
[patent_doc_number] => 20080166322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'METHODS FOR PRODUCING AN ADENOVIRUS TYPE 5 GENE TRANSFER VECTOR'
[patent_app_type] => utility
[patent_app_number] => 11/953306
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7842
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20080166322.pdf
[firstpage_image] =>[orig_patent_app_number] => 11953306
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/953306 | METHODS FOR PRODUCING AN ADENOVIRUS TYPE 5 GENE TRANSFER VECTOR | Dec 9, 2007 | Abandoned |
Array
(
[id] => 4764616
[patent_doc_number] => 20080175827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY'
[patent_app_type] => utility
[patent_app_number] => 11/942406
[patent_app_country] => US
[patent_app_date] => 2007-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 23231
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175827.pdf
[firstpage_image] =>[orig_patent_app_number] => 11942406
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/942406 | PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY | Nov 18, 2007 | Abandoned |
Array
(
[id] => 9254856
[patent_doc_number] => 08618273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-31
[patent_title] => 'Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same'
[patent_app_type] => utility
[patent_app_number] => 12/447044
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6910
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12447044
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/447044 | Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same | Oct 23, 2007 | Issued |
Array
(
[id] => 4608669
[patent_doc_number] => 07993924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses'
[patent_app_type] => utility
[patent_app_number] => 11/899492
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 14780
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/993/07993924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11899492
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/899492 | cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses | Sep 5, 2007 | Issued |
Array
(
[id] => 4909697
[patent_doc_number] => 20080020463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Entrapped stem cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/891526
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3951
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020463.pdf
[firstpage_image] =>[orig_patent_app_number] => 11891526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/891526 | Entrapped stem cells and uses thereof | Aug 9, 2007 | Issued |
Array
(
[id] => 6549442
[patent_doc_number] => 20100233125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/438238
[patent_app_country] => US
[patent_app_date] => 2007-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7940
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233125.pdf
[firstpage_image] =>[orig_patent_app_number] => 12438238
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/438238 | CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME | Aug 8, 2007 | Abandoned |
Array
(
[id] => 4803574
[patent_doc_number] => 20080015163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'MICE LACKING ALPHA 1G SHOWING ENHANCED NOVELTY-SEEKING AND ALCOHOL PREFERENCE AND THERAPEUTIC METHODS FOR MOOD DISORDERS BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 11/782771
[patent_app_country] => US
[patent_app_date] => 2007-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6582
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015163.pdf
[firstpage_image] =>[orig_patent_app_number] => 11782771
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/782771 | MICE LACKING ALPHA 1G SHOWING ENHANCED NOVELTY-SEEKING AND ALCOHOL PREFERENCE AND THERAPEUTIC METHODS FOR MOOD DISORDERS BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS | Jul 24, 2007 | Abandoned |